Benjamin Bader

2-HETEROARYL-3-OXO-2,3-DIHYDROPYRIDAZINE-4-CARBOXAMIDES FOR THE TREATMENT OF CANCER

FUSED PYRIMIDINES AS KRAS INHIBITORS

2-HETEROARYL-3-OXO-2,3-DIHYDROPYRIDAZINE-4-CARBOXAMIDES FOR THE TREATMENT OF CANCER

PHOSPHORUS DERIVATIVES AS NOVEL SOS1 INHIBITORS

2-Methyl-Quinazolines

PYRIDO[2,3-D]PYRIMIDIN-4-AMINES AS SOS1 INHIBITORS

Substituted aminoquinolones as DGKalpha inhibitors for immune activation

SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION

SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION

SUBSTITUTED AMINOQUINOLONES AS DGKALPHA INHIBITORS FOR IMMUNE ACTIVATION

Substituted aminothiazoles as DGKzeta inhibitors for immune activation

2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer

[1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINES

2-METHYL-AZA-QUINAZOLINES

2-METHYL-AZA-QUINAZOLINES

2-METHYL-QUINAZOLINES

IDENTIFICATION AND USE OF KRAS INHIBITORS

4-(3-AMINO-6-FLUORO-1H-INDAZOL-5-YL)-1,2,6-TRIMETHYL-1,4-DIHYDROPYRIDINE-3,5-DIC ARBONITRILE COMPOUNDS FOR TREATING HYPERPROLIFERATIVE DISORDERS

2-(morpholin-4-yl)-1,7-naphthyridines

Sulphur substituted 3-oxo-2,3-dihydropyridazine-4-carboxamides

2-hetarylpyrimidine-4-carboxamides as aryl hydrocarbon receptor antagonists

3-oxo-6-heteroaryl-2-phenyl-2,3-dihydropyridazine-4-carboxamides

2-phenylpyrimidine-4-carboxamides as AHR inhibitors

3-oxo-2,6-diphenyl-2,3-dihydropyridazine-4-carboxamides

[4-(PHENYLSULFONYL)PIPERAZIN-1-YL](1H-1, 2, 3-TRIAZOL-4-YL)METHANONES

[(PHENYLSULFONYL)OCTAHYDRO-EPIMINOISOINDOL-YL](1H-1,2,3-TRIAZOL-5-YL)METHANONES

[4-(PHENYLSULFONYL)PIPERAZIN-1-YL](1H-1,2,3-TRIAZOL-4-YL)METHANONES

5-substituted 2-(morpholin-4-yl)-1,7-naphthyridines

Heteroarylbenzimidazole compounds

[8-(PHENYLSULFONYL)-3,8-DIAZABICYCLO[3.2.1]OCT-3-YL](1H-1,2,3-TRIAZOL-4-YL)METHANONES

2-(morpholin-4-yl)-1,7-naphthyridines

[8-(phenylsulfonyl)-3,8-diazabicyclo[3.2.1]oct-3-yl](1H-1,2,3-triazol-4-yl)methanones

2-(morpholin-4-yl)-1,7-naphthyridines

Substituted triazolopyridines

2-(morpholin-4-yl)-1,7-naphthyridines

SUBSTITUTED DIHYDROPYRIDO[3,4-B]PYRAZINONES AS DUAL INHIBITORS OF BET PROTEINS AND POLO-LIKE KINASES

NOVEL COMPOUNDS FOR THE TREATMENT OF CANCER

BET-PROTEIN-INHIBITING DIHYDROPYRIDOPYRAZINONES

Amino-substituted isothiazoles

-[4-(quinolin-4-yloxy)cyclohexyl(methyl)](hetero)arylcarboxamides as androgen receptor antagonists, production and use thereof as medicinal products

6 SUBSTITUTED IMIDAZOPYRAZINES FOR USE AS MPS-1 AND TKK INHIBITORS IN THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS

OXO-SUBSTITUTED IMIDAZO[1,2B]PYRIDAZINES, THEIR PREPARATION AND USE AS PHARMACEUTICALS

6-SUBSTITUTED IMIDAZOPYRAZINES FOR USE AS MPS-1 AND TKK INHIBITORS IN THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS

IMIDAZOPYRAZINES FOR USE AS MPS-1 AND TKK INHIBITORS IN THE TREATMENT HYPERPROLIFERATIVE DISORDERS

6-thio-substituted imidazo[1,2-a]pyrazines as Mps-1 inhibitors

Substituted imidazo[1,2-a]pyrazines as MPS-1 inhibitors

Substituted imidazopyrazines

Imidazopyrazines

Substituted triazolopyridines

TRIAZOLOPYRIDINE DERIVATIVES

Substituted triazolopyridines

Triazolopyridines

Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors

Substituted imidazoquinoxalines

SUBSTITUTED PHENYLAMINO-BENZENE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH MITOGEN EXTRACELLULAR KINASE ACTIVITY

Oxo-substituted imidazo[1,2B]pyridazines, their preparation and use as pharmaceuticals

3-amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents

SUBSTITUTED ISOXAZOLINES, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, METHODS OF PREPARING SAME, AND USES OF SAME

Macrocyclic anilinopyrimidines with substituted sulphoximine as selective inhibitors of cell cycle kinases

Substituted imidazo[1,2b]pyridazines as kinase inhibitors, their preparation and use as medicaments

Quinoline derivative, its use, production and pharmaceutical agents containing the latter